10 year sector competitiveness plan for Medical Technologies and Pharmaceuticals
August 2016 We want to know if we’ve got it right, said Sue MacLeman, CEO of MTPConnect at the launch of the 10 year Sector Competitiveness Plan – which is still in draft form. The plan outlines seven…
Launch Vic Collaboration (July 2016)
July 2016 BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch…
Meeting with the Hon Wade Noonan MP
July 2016 BioMelbourne Network CEO, Dr Krystal Evans and Chair, Mr Andrew Carter held an introductory meeting with the Hon Wade Noonan, Minister for Industry and Employment. Minister Noonan was appointed into this role in May and has…
Two new strategies launched (July 2016)
July 2016 In July, Victorian Health Minister Jill Hennessy launched two new government strategies: Victoria’s Health and Medical Research Strategy 2016-20: Healthier lives, stronger economy Victoria’s International Health Strategy 2016 – 2020: Partnering for a healthy and prosperous future…
Gender Equality and Innovation (April 2016)
18 April 2016 It’s time to do things differently in Australia and be bolder in our commitment to diversity, says CEO of the BioMelbourne Network Dr Krystal Evans. SCIENCE MEETS BUSINESS Though Leadership Series. Click here for full…
Federal Budget: Scientists Push for More Research Funding
April 2016 Dr Krystal Evans – CEO, BioMelbourne Network comments in Sydney Morning Herald article: The May budget is shaping as a crucial test of Prime Minister Malcolm Turnbull’s innovation credentials, with leading Australian scientists urging his government to move beyond slogans and invest…
NISA Engagement and Impact Assessment Consultation Paper
June 2016 BioMelbourne Network welcomed the opportunity to contribute a submission in response to the National Innovation & Science Agenda (NISA) Engagement and Impact Assessment Consultation Paper. Research engagement and impact is a very important issue for BioMelbourne…
Response to Medical Technology and Pharmaceuticals Discussion Paper
September 2015 In September 2015, BioMelbourne Network welcomed the opportunity to contribute to the Medical Technology and Pharmaceuticals Discussion Paper produced by the Victorian Government’s Department of Economic Development, Jobs, Transport and Resources. This Paper formed part of…
Women in STEM and Entrepreneurship Roundtable Discussion
April 2016 In April 2016, Dr Krystal Evans participated in a roundtable discussion on “Women in STEM and Entrepreneurship” in Canberra. The aim of this roundtable was to bring together key representatives from Government, industry, research and education to…
R&D Tax Incentive Review (February 2016)
February 2016 The R&D tax incentive is a highly successful policy programme has helped many Australian biotechnology and medical technology businesses to undertake additional R&D activities and to successfully create innovative health care products for the global export…
MRFF Submission (June 2016)
June 2016 The MRFF will be used to drive medical innovation, and is a massive opportunity to boost research translation and accelerate the development of discoveries into clinical reality in Australia. The Australian Medical Research Advisory Board held…
Focus Group – Trade Victoria (May 2016)
May 2016 On 11th of May, CEO Dr Krystal Evans was invited to contribute to an industry focus group on Trade Victoria, to provide perspectives on the current level of industry understanding and engagement with Trade Victoria’s service…
